Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS

Alemtuzumab is a highly effective therapy for relapsing-remitting MS (RRMS) with secondary autoimmunity as a main adverse event. Here, we present a case of microscopic polyangiitis (MPA) in a patient with RRMS secondary to alemtuzumab therapy.

Source: Neurology Neuroimmunology and Neuroinflammation - August 10, 2018 Category: Neurology Authors: Sauer, E.-M., Schliep, S., Manger, B., Lee, D.-H., Linker, R. A. Tags: All Immunology, Autoimmune diseases, Vasculitis, Multiple sclerosis Clinical/Scientific Notes Source Type: research